Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCL8 | P10145 | 10/20 | 0.63 |
| ▸ | NMBR | P28336 | 1/20 | 0.59 |
| ▸ | GRPR | P30550 | 1/20 | 0.59 |
| ▸ | CCKBR | P32239 | 4/20 | 0.58 |
| ▸ | GLP1R | P43220 | 4/20 | 0.58 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.58 |
| ▸ | CALCR | P30988 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30432412 | 0.87 | GLP1R (0.64) | CCKBRGLP1RCALCR | |
| SCHEMBL9073302 | 0.84 | KISS1R (0.66) | NMBRGRPRKISS1R | |
| SCHEMBL31238594 | 0.84 | KISS1R (0.62) | NMBRGRPRKISS1R | |
| SCHEMBL30432320 | 0.84 | CCKBR (0.60) | CXCL8NMBRGRPRCCKBRGLP1R | |
| SCHEMBL29663694 | 0.84 | CXCL8 (0.59) | CXCL8NMBRGRPRKISS1R | |
| SCHEMBL31182548 | 0.83 | GLP1R (0.70) | CCKBRGLP1RCALCR | |
| SCHEMBL30572393 | 0.83 | C5AR1 (0.61) | NMBRGRPRCCKBRGLP1RKISS1R | |
| SCHEMBL30432727 | 0.83 | APLNR (0.63) | GLP1R | |
| SCHEMBL29416123 | 0.82 | CXCR4 (0.60) | CXCL8NMBRGRPRCCKBRGLP1R | |
| SCHEMBL31544061 | 0.82 | C5AR1 (0.73) | NMBRGRPRGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118356478-A | Application of Fz7-21 in Alzheimer disease and brain aging | 沈阳药科大学 | 2024-07-19 | — | — | CN | claimed |
| CN-118356478-A | Application of Fz7-21 in Alzheimer disease and brain aging | 沈阳药科大学 | 2024-07-19 | — | — | CN | disclosed |